Immune-response modifiers: a new paradigm in the treatment of human papillomavirus
Open Access
- 1 September 2000
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 61 (9) , 584-596
- https://doi.org/10.1016/s0011-393x(00)88011-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Prevalence of human papilloma virus in men attending the infertility clinicAndrologia, 2009
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- CONDYLOMA ACUMINATUMInternational Journal of Dermatology, 1995
- Short-term systemic recombinant interferon-γ treatment is ineffective in recalcitrant condylomata acuminataJournal of the American Academy of Dermatology, 1991
- Interferon Therapy for Condylomata AcuminataNew England Journal of Medicine, 1986
- Latent Papillomavirus and Recurring Genital WartsNew England Journal of Medicine, 1985
- Intralesional Administration of Large Doses of Human Leukocyte Interferon for the Treatment of Condylomata AcuminataThe Journal of Infectious Diseases, 1984
- Systemic Interferon Alpha Treatment of Human Condylomata AcuminataActa Obstetricia et Gynecologica Scandinavica, 1983